InvestorsHub Logo

hnbadger1

09/25/21 2:55 PM

#331030 RE: blue finch #331027

Don’t think so. He is a hard core long.

powerwalker

09/25/21 2:59 PM

#331031 RE: blue finch #331027

mr, nidan was not frustrated. Here is his last post:

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=165636617

... with that, a poster is able to visit nidan's history and read his past posts. He was encouraging, helpful and reflected calm. mr, I think you are mistaken.

He has not posted since 8/26, so tomorrow is a month that he hasn't posted for the general public to read.

If anyone received a PM from him since, please let us know.

Otherwise, he be with bennyboy and ipulator. God bless all of them.

Peace,
powerwalker


ANAVEX NOW ... RIGHT NOW ... MONO-STYLE ... for LIFE ... and for ALL AGES!!!

tredenwater2

09/25/21 4:39 PM

#331042 RE: blue finch #331027

The “figure it outon the back of a napkin” comment sure didnt seem like we would be charging $3,000 a year for Rett patients. Maybe he mentioned some number that I cant recall but I think he is very optimistic that this will be a good starting revenue generator. Would be nice once revenue really starts pouring in to reduce what we charge for Rare diseases. Just doesnt seem right to charge a high price given the cards they have been dealt and the family members struggles (which are blessings in disguise)!

Tred

samk

09/25/21 7:32 PM

#331053 RE: blue finch #331027

'Are they anticipating manufacturing and selling the drug on their own which is a big undertaking and very complicated'

If RETT approved, RETT foundation will let every patient/parent know...
Although AVXL has manufacturing capability for RETT, it will require a partner for PDD, PD(motor), AD and other CNS drugs in the pipeline.

Another theory - ANVX might need another shelf(one already exists) for hostile takeover attempt after very good trial data is published.
ALL IMHO.